Sangam Health Care Says No Debt, Stays Out of SEBI 'Large Corporate'

OTHER
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Sangam Health Care Says No Debt, Stays Out of SEBI 'Large Corporate'
Overview

Sangam Health Care Products Ltd. has confirmed it is not a 'Large Corporate' (LC) under SEBI rules because it has zero outstanding borrowing as of March 31, 2026. This status means the company avoids the strict disclosure and compliance requirements that LCs must follow when raising debt, giving it a different path for fundraising.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Sangam Health Care Avoids 'Large Corporate' Status with Zero Debt

Sangam Health Care Products Ltd. has officially notified the stock exchange that it does not meet the criteria to be classified as a 'Large Corporate' (LC) under SEBI's framework. The company reported zero outstanding borrowing as of March 31, 2026. This classification means Sangam Health Care is exempt from the stricter disclosure and compliance rules that apply to LCs, especially when issuing debt securities.

SEBI introduced the 'Large Corporate' framework to develop the corporate debt market, requiring certain companies to raise funds through debt with enhanced reporting. Companies below the LC threshold, like Sangam Health Care, face different fundraising and disclosure requirements, which can offer more flexibility.

Established in 1993, Sangam Health Care Products Ltd. manufactures medical disposables and surgical products under the SAFTI brand. The company has faced financial challenges, reporting a significant decrease in revenue and profit in FY21. The SEBI 'Large Corporate' framework generally targets companies with substantial long-term borrowings and strong credit ratings, typically 'AA' or above. For instance, Sangam India Ltd. was also excluded from LC status despite having significant borrowings, due to a credit rating below the 'AA' benchmark. A recent critical event was Sangam Health Care's delisting from the BSE in November 2024 for non-compliance, with a relisting process now underway. The company also has open charges amounting to ₹52.23 crore.

The company now benefits from greater flexibility in its debt issuance and compliance procedures. It can explore fundraising options beyond the specific mandates of the LC framework, while still needing to adhere to general regulatory disclosure standards.

Key concerns for stakeholders include the ongoing relisting process following the BSE delisting. Past financial performance also indicates potential revenue and profitability vulnerabilities. The status of the company's outstanding charges remains a point to monitor.

While direct peers facing similar LC status clarifications are scarce, Sangam India Ltd. offers a comparison. Sangam India Ltd. also missed the 'Large Corporate' tag for FY26, not due to debt levels, but because its credit rating (IND A-/Stable) fell below SEBI's 'AA' threshold, despite substantial borrowings. This illustrates that creditworthiness is a key factor alongside debt size for LC classification.

Investors and observers will track the progress and outcome of the BSE relisting process. Future fundraising plans or announcements from the company, as well as subsequent financial performance updates, will also be key. Any changes to SEBI's 'Large Corporate' framework applicability will be relevant.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.